Name: BRISTOL-MYERS SQUIBB CO (BMY) Stock
Brand: BRISTOL-MYERS SQUIBB CO
Rating: 5.5 (3 reviews)

BMY Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill

Bristol Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case

8 days ago - By: Chartmill

Bristol-Myers Squibb Co (NYSE:BMY) Offers a Compelling Mix of High Yield and Dividend Growth

17 hours ago - By: Zacks Investment Research - Mentions: NVO PRTA

Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus

3 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes

3 days ago - By: Zacks Investment Research

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

5 days ago - By: Benzinga - Mentions: CI LLY UNH SUPN ...

10 Health Care Stocks Whale Activity In Today's Session

5 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025

5 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

9 days ago - By: Chartmill - Mentions: MO IP VTR CI ...

Discover which S&P500 stocks are making waves on Thursday.

9 days ago - By: Stocktwits - Mentions: DUHP EAOR

BMY CEO Expects Cancer Drug Opdivo To Drive Strong Sales In 2025

9 days ago - By: Zacks Investment Research - Mentions: PFE ALKS BNTX

BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View

9 days ago - By: Chartmill

Bristol Myers Squibb Co (NYSE:BMY) Q3 2025 Earnings Beat Estimates

9 days ago - By: Benzinga - Mentions: IR CDP ENTG BUD ...

Earnings Scheduled For October 30, 2025

9 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Reports Third Quarter Financial Results for 2025

9 days ago - By: Bloomberg

Bristol Myers Beats Quarterly Expectations on New Drug Demand

12 days ago - By: The Motley Fool - Mentions: PFE MRK

3 Dividend-Paying Drug Stocks to Buy at a Discount

12 days ago - By: Zacks Investment Research - Mentions: PFE BNTX

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

12 days ago - By: Zacks Investment Research

Ahead of Bristol Myers (BMY) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

12 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus

12 days ago - By: Yahoo Finance - Mentions: MSFT AMZN AAPL XOM ...

Big Tech earnings, a crucial Fed meeting, and a Trump-Xi sit-down: What to watch this week

14 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025

16 days ago - By: Zacks Investment Research

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for

16 days ago - By: The Motley Fool - Mentions: TTD AMZN PEP CELH ...

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks

19 days ago - By: Zacks Investment Research - Mentions: PFE BNTX

BRISTOL-MYERS SQUIBB CO (BMY) Stock News